Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis. - Wikidata - wikimedia - TriplyDB

Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis.

Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis.

http://www.wikidata.org/entity/Q34912890

about

Ultrasonographic assessment reveals detailed distribution of synovial inflammation in Blau syndrome.Blau syndrome polymorphisms in NOD2 identify nucleotide hydrolysis and helical domain 1 as signalling regulators Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's disease Blau syndrome, the prototypic auto-inflammatory granulomatous disease Monogenic autoinflammatory diseases: new insights into clinical aspects and pathogenesis.LRRK2 and RIPK2 variants in the NOD 2-mediated signaling pathway are associated with susceptibility to Mycobacterium leprae in Indian populations Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kind Blau syndrome: cross-sectional data from a multicentre study of clinical, radiological and functional outcomes.NOD2/CARD15 gene mutations in North Algerian patients with inflammatory bowel disease.A new category of autoinflammatory disease associated with NOD2 gene mutations.NOD2/CARD15 gene mutation identified in a Chinese family with Blau syndrome.Structures of the inactive and active states of RIP2 kinase inform on the mechanism of activation.Association of a NOD2 gene polymorphism and T-helper 17 cells with presumed ocular toxoplasmosis.Blau syndrome-associated Nod2 mutation alters expression of full-length NOD2 and limits responses to muramyl dipeptide in knock-in mice.A discrete ubiquitin-mediated network regulates the strength of NOD2 signaling.Pulmonary sarcoid-like granulomatous disease in an 11-month-old girl Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues The plodding diagnosis of monogenic autoinflammatory diseases in childhood: from the clinical scenery to laboratory investigation.The puzzling clinical spectrum and course of juvenile sarcoidosis.Clinical and biochemical landmarks in systemic autoinflammatory diseases.Pattern recognition receptors in immune disorders affecting the skin.Ubiquitination and phosphorylation in the regulation of NOD2 signaling and NOD2-mediated disease Blau syndrome-associated uveitis and the NOD2 gene.Early-onset sarcoidosis caused by a rare CARD15/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature.Untangling the web of systemic autoinflammatory diseases.Early diagnosis of early-onset sarcoidosis: a case report with functional analysis and review of the literature.Two Chinese pedigrees of Blau syndrome with thirteen affected members.Familial aggregation of Crohn's disease and necrotizing sarcoid-like granulomatous disease.Brief Report: First Identification of Intrafamilial Recurrence of Blau Syndrome due to Gonosomal NOD2 Mosaicism.NOD2-associated autoinflammatory disease: a large cohort study.[Autoinflammatory syndromes/fever syndromes].In vivo inhibition of RIPK2 kinase alleviates inflammatory disease.A new mutation in blau syndrome.Distinguishing between the innate immune response due to ocular inflammation and infection in a child with juvenile systemic granulomatous disease treated with anti-TNFα monoclonal antibodies.Optic nerve and retinal features in uveitis associated with juvenile systemic granulomatous disease (Blau syndrome).Identification of Potent and Selective RIPK2 Inhibitors for the Treatment of Inflammatory Diseases.A case of infantile Takayasu arteritis with a p.D382E NOD2 mutation: an unusual phenotype of Blau syndrome/early-onset sarcoidosis?The different roles of innate immune receptors in inflammation and carcinogenesis between races.A 21-Month-Old Male With Refusal to Walk, Rash, and Weight Loss.A novel nucleotide oligomerisation domain 2 mutation in a family with Blau syndrome: Phenotype and function.

P2860

Q22000829-807EEAD0-7643-4E56-8C6B-1092D90B277B Q24301721-0D4F80C2-0207-4099-B6F5-5C70B8374B59 Q26778253-F0F8E78B-7CEB-413D-AF3C-718CF6A25139 Q34060987-F5199721-4212-4AB2-887B-8FE4AD956F43 Q34489840-45EE0DCE-E716-4378-A216-0F3A721C95AD Q34981661-F1103816-79F4-4340-B1E6-B981804D1778 Q35190461-17FA9DE2-CC88-4F98-A15A-67051B76530E Q35443835-E30A8636-A52E-46B3-BA65-E7156F4E55B6 Q35819548-75B656BC-EA9E-4863-94B0-BE00A11D5727 Q35840739-EFBD36D4-E469-4561-A5DD-80975438B5CE Q35883296-19E85D90-EC33-4D3A-83DF-511C34AD1EA7 Q36381630-CDB537E1-3920-49A2-B4A0-4388A0D76B9C Q36471061-A4CD727C-75C2-4FC6-8839-ADA4C545A320 Q36490486-EBC08722-D44E-4B23-80D8-64CE589807D0 Q36506610-3DF9965E-544B-4968-99E4-30ECF441A673 Q36818089-FA3DD674-C52B-4CF6-A26C-3C4407973AE7 Q37299354-15B5F3CA-21CD-4D32-894D-99D857AD2481 Q37833103-44CD06D6-CC3B-4FDB-A87C-A7A42F0D3758 Q37875801-E2501C21-BE92-42D8-ACEC-135094C307B8 Q37942581-8B029FFE-74BF-4B59-9873-4EFA09FA515C Q37991471-19ED5D1F-8FDF-445C-9C87-B38588B7371B Q38004338-8C566421-CA85-43BD-901F-9694218165CE Q38134785-28898622-9B77-4851-B985-BC008EA33CEE Q38180294-1DC786AF-1991-44AF-932C-642AEEFFC21F Q38240838-6462B95E-41A6-433F-82F1-94760639D1DD Q39107230-51D2E13C-E120-4899-AB01-EA9D9AFCF8CC Q39443258-DEC6ECA9-183C-469B-8BDA-EA2739444DAD Q40086222-C65AEB6C-EC81-427E-998D-7750E7BD4962 Q40129439-60DFE4D5-AE28-4D29-9A78-942E03D9BD69 Q40151734-6AC9C66C-725F-4A2C-941E-EF68D5A20EAA Q40326095-8CC1A3C7-512C-446C-A087-C64A9F782F0A Q41742020-5900B94C-16DD-4AB5-99EC-1CB44CC9B336 Q41884305-ADB94930-A43F-4124-A96D-8FCC30EDD9EC Q42717829-EB6F48C7-6E13-48C6-ACB8-DC9137D37DE0 Q43861706-2CDF2952-A895-4AC3-9CA3-A194CFCD9CE7 Q45952614-61973DEE-2CEF-424A-9E7C-0CDFFE390527 Q46507841-4518B4A5-F986-4806-BAFE-55F9C4E66298 Q47133267-9DD8BC9F-77AB-4998-A311-C9A1B13EFA4D Q47344620-2D8774E3-2B7A-44BB-828F-6895F917D7B8 Q47911970-1766EF4C-499D-4469-A547-729B35131022

P2860

Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis.

http://www.wikidata.org/entity/Q34912890

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Role of the NOD2 genotype in t ...... e and early-onset sarcoidosis.

@ast

Role of the NOD2 genotype in t ...... e and early-onset sarcoidosis.

@en

Role of the NOD2 genotype in t ...... e and early-onset sarcoidosis.

@nl

type

label

Role of the NOD2 genotype in t ...... e and early-onset sarcoidosis.

@ast

Role of the NOD2 genotype in t ...... e and early-onset sarcoidosis.

@en

Role of the NOD2 genotype in t ...... e and early-onset sarcoidosis.

@nl

prefLabel

Role of the NOD2 genotype in t ...... e and early-onset sarcoidosis.

@ast

Role of the NOD2 genotype in t ...... e and early-onset sarcoidosis.

@en

Role of the NOD2 genotype in t ...... e and early-onset sarcoidosis.

@nl

P1433

Q34912890-479240FC-8AE3-46C7-9774-2A0AB51CE703

P1476

Q34912890-A751E095-D45E-49F9-A693-C932915E75AD

P2093

Q34912890-046F2E33-4BD0-42CF-9918-FB34F221680C

Q34912890-08DC8CD8-5706-4F38-8DC9-D2A0D8085FCB

Q34912890-2EC319D9-9302-47F5-AAC5-772B041D6BBC

Q34912890-365A237A-CCC2-476F-A696-7F4F2BEF9DD5

Q34912890-41103757-1205-4AE7-8E9E-1827285FDF0A

Q34912890-4489E9B9-B8E7-460E-87DB-4285E11AEBD0

Q34912890-70913FEE-157D-48A8-A02B-B07C56AAA34C

Q34912890-802AFC68-DE46-4EE8-AC53-97009BB72CA2

Q34912890-A72EFF98-4D84-40AB-A85A-ED8F978A0C26

Q34912890-A9A51556-881D-431E-BDF4-5FDDDAA59238

P304

Q34912890-FC96B2E1-FC45-4201-A6C9-D57CAAA6C4BC

P31

Q34912890-81786702-69A9-4E35-A153-CA1974E9AAC5

P356

Q34912890-DA8D26BA-D4C2-4D0E-A4CF-D89D2E2898AE

P433

Q34912890-175772F9-ED5D-4151-8B70-2855145C87BC

P478

Q34912890-AA1B6517-A1B2-4A4C-AA5C-81B33468216D

P50

Q34912890-8B89EC11-6F71-4576-ACA5-DE72581FB78A

Q34912890-E0E495F6-00BC-4C6B-99E5-6B12E7E3D21B

P577

Q34912890-AC2BA6C0-B351-4E59-B453-61D8901FB182

P5875

Q34912890-0136B54F-A453-4BAB-AC7C-9C2BCC1F06E4

P698

Q34912890-81CC8D21-431E-433E-9396-C88FBEFCAFFB

P356

P1433

Arthritis and Rheumatism

P1476

Role of the NOD2 genotype in t ...... me and early-onset sarcoidosis

@en

P2093

Akihiro Fujisawa

http://www.w3.org/2001/XMLSchema#string

Hideaki Tanizaki

http://www.w3.org/2001/XMLSchema#string

Hidemasa Sakai

http://www.w3.org/2001/XMLSchema#string

Ikuo Okafuji

http://www.w3.org/2001/XMLSchema#string

Megumu Saito

http://www.w3.org/2001/XMLSchema#string

Ryuta Nishikomori

http://www.w3.org/2001/XMLSchema#string

Shin Yamazaki

http://www.w3.org/2001/XMLSchema#string

Takakazu Yoshioka

http://www.w3.org/2001/XMLSchema#string

Tatsutoshi Nakahata

http://www.w3.org/2001/XMLSchema#string

Tomoki Kawai

http://www.w3.org/2001/XMLSchema#string

P304

242-250

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.24134

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23714122

http://www.w3.org/2001/XMLSchema#string

P698

19116920

http://www.w3.org/2001/XMLSchema#string